Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies. Eichenauer DA, Buhnen I, Baues C, Kobe C, et al. Blood 2023;142:553-560.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Eichenauer DA, Buhnen I, Baues C, Kobe C, et al. Interim PET-guided treatment for early-stage NLPHL: a subgroup analysis of the randomized GHSG HD16 and HD17 studies. Blood 2023;142:553-560.
PMID: 37257195